ENTERO HEALTHCARE BUSINESS
Hot Stocks: Brokerages on RIL, Entero Healthcare, Natco Pharma and Persistent Systems
Brokerage Nomura upheld a neutral rating on Persistent Systems, while Investec continues to advocate a buy stance on Natco Pharma and has initiated a buy recommendation on Entero Healthcare. Conversely, CLSA has downgraded RIL to an outperform rating.
Hot Stocks: Brokerages on Entero, CreditAccess, Bharti Hexacom, Interglobe and PVR
Brokerages initiate coverage and recommendations on Entero Healthcare, CreditAccess, Bharti Hexacom. Indigo Aviation downgraded by Axis Capital and Investec. CLSA retains buy on PVR Inox, emphasizing multiplexes as popular outdoor entertainment with growth plans in South India.
Entero Healthcare Solutions IPO allotment: Check status, GMP, listing date and other details
To check the status of Entero Healthcare Solutions allotment through the registrar, which is Bigshare Services in this case, kindly follow the below steps.
Entero Healthcare is going to expand more into tier II, tier III cities now
"In the last three years, our average annual growth rate has been 36% and once the IPO proceeds and we receive that money, we will be even more aggressive in terms of pursuing growth opportunities. In terms of business mix, 95% is coming from distribution services, but we also provide a lot of value-added services to these companies in terms of providing marketing and promotion services as well but that contributes less than 5% of our business as of now."
Vibhor Steel Tubes among 4 IPOs set to hit the Street this week. Check details
As the third quarter earnings are about to end, inflows into the primary market are expected to continue as several companies prepare to launch their public offerings this week.
Massive growth opportunities for healthcare industry in India: Entero Healthcare MD
“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-and-a-half thousand hospitals.”
- Go To Page 1
IPO Calendar: Primary market to breathe easy with only 2 IPOs scheduled next week
The Street will see a flurry of listings, four of them in the mainboard segment. Three IPOs of Rashi Peripherals, Jana SFB and Capital SFB opened last week and closed for subscription. The listings of these three public offers are scheduled for next week.
ETIG IPO Analysis: Entero Healthcare may Offer Better Value Post Listing
Incorporated in 2018 and founded by a former chief executive of Alkem Laboratories, Mumbai-based Entero Healthcare Solutions has grown to be among India's top three pharma distribution companies.
Entero Healthcare IPO: Should you subscribe to this Rs 1600 crore issue?
Entero Healthcare recorded a 31% YoY increase in revenue from operations during FY23, reaching Rs 3,300 crore. ICICI Securities, Dam Capital Advisors, Jefferies India, JM Financial, and SBI Capital Markets are the book running lead managers for the IPO.
Entero Healthcare's Rs 1,600-cr IPO biggest so far in 2024: 10 things to know before subscribing to the issue
The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.
Three IPOs to hit primary mkt on Wednesday; aim to raise Rs 1,700-cr
Market experts maintain a strong bullish outlook on the IPO (initial public offering) market for 2024. Companies are expecting to benefit from an equity market which is flush with liquidity and has seen a sharp increase in new retail investors.
Load More
